Monogram Historical Cash Flow
| MGRM Stock | 2.00 0.07 3.38% |
Analysis of Monogram Orthopaedics cash flow over time is an excellent tool to project Monogram Orthopaedics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 1.3 M or Depreciation of 433 K as it is a great indicator of Monogram Orthopaedics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Monogram Orthopaedics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Monogram Orthopaedics is a good buy for the upcoming year.
Monogram |
About Monogram Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Monogram balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Monogram's non-liquid assets can be easily converted into cash.
Monogram Orthopaedics Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Capital Expenditures
Capital Expenditures are funds used by Monogram Orthopaedics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Monogram Orthopaedics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Total Cashflows From Investing Activities
The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.Most accounts from Monogram Orthopaedics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Monogram Orthopaedics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Monogram Orthopaedics' Change In Working Capital is very stable compared to the past year. As of the 29th of November 2024, Depreciation is likely to grow to about 433 K, while Stock Based Compensation is likely to drop about 969.2 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 1.0M | 241.2K | 64.9K | 61.7K | Depreciation | 322.0K | 386.7K | 412.3K | 433.0K |
Monogram Orthopaedics cash flow statement Correlations
Click cells to compare fundamentals
Monogram Orthopaedics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Monogram Orthopaedics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.4M | 3.3M | (51.0K) | 4.9M | 3.1M | 2.1M | |
| Free Cash Flow | (1.1M) | (6.7M) | (10.2M) | (8.7M) | (13.6M) | (12.9M) | |
| Change In Working Capital | 101.2K | (811.1K) | 556.0K | 709.6K | 1.1M | 1.2M | |
| Other Cashflows From Financing Activities | 2.5M | 10.8M | 10.1M | 13.6M | 1.4M | 1.3M | |
| Depreciation | 31.8K | 95.7K | 322.0K | 386.7K | 412.3K | 433.0K | |
| Capital Expenditures | 5.4K | 1.3M | 1.0M | 241.2K | 64.9K | 61.7K | |
| Total Cash From Operating Activities | (1.0M) | (5.4M) | (9.2M) | (8.4M) | (13.5M) | (12.9M) | |
| Net Income | (1.8M) | (9.1M) | (11.8M) | (13.7M) | (13.7M) | (13.1M) | |
| Total Cash From Financing Activities | 2.5M | 10.0M | 10.1M | 13.6M | 16.7M | 8.7M | |
| End Period Cash Flow | 2.3M | 5.6M | 5.5M | 10.5M | 13.6M | 14.3M | |
| Begin Period Cash Flow | 922.1K | 2.3M | 5.6M | 5.5M | 10.5M | 11.0M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.012 | Return On Assets (0.61) | Return On Equity (1.22) |
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.